Core Laboratories (CLB)

NYSE Market Closed

Core Laboratories Inc. is an oilfield services company focused on helping exploration and production companies understand reservoirs and improve hydrocarbon recovery. Its work is centred on the science of rocks, fluids, pressure behaviour, and well performance, giving operators technical data they can use to make drilling, completion, and production decisions.

The company reports through two main businesses: Reservoir Description and Production Enhancement. Reservoir Description provides laboratory analysis, field services, and interpretation of core samples, reservoir fluids, and related geological data. These services help customers assess reservoir quality, estimate reserves, model production potential, and determine how crude oil and natural gas can be recovered and processed more efficiently. This segment is typically the company’s largest source of revenue.

Production Enhancement supplies technologies and services used to increase output from existing and newly completed wells. Its offerings include diagnostic tools, completion products, and systems that support perforating, stimulation, and reservoir monitoring. Core Laboratories also manufactures specialised equipment used in its laboratory and field-service activities, giving it a proprietary product base alongside its consulting and analytical work.

The company serves oil and gas producers around the world and is closely tied to upstream spending, reservoir development activity, and the industry’s focus on extracting more value from existing assets. Its competitive position rests on patented technologies, long-standing customer relationships, and technical expertise in reservoir evaluation rather than on large-scale drilling or commodity production.

13.66 USD
13.06 USD
+0.30 (+2.25%)
After-hours

Last updated

Market Cap
615.85M
P/E
21.4
P/FCF
33.41
P/S
1.17
Enterprise Value
707.49M
Sector
Energy
Industry
Oil and Gas Field Services, Not Elsewhere Classified
Address
6316 WINDFERN ROAD, HOUSTON, TX, 77040
GlobeNewswire Inc.

Christina Lake Cannabis Announces Filing of Q1 Financial Statements

26 Jun 2024, 00:54 AM
GlobeNewswire Inc.

Christina Lake Cannabis Announces Filing of Audited Financial Statements

18 Jun 2024, 12:00 PM
GlobeNewswire Inc.

Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO

03 Jun 2024, 23:23 PM
GlobeNewswire Inc.

Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO

30 May 2024, 01:20 AM
Zacks Investment Research

Core Laboratories (CLB) Up 6.2% Since Last Earnings Report: Can It Continue?

24 May 2024, 16:31 PM
GlobeNewswire Inc.

Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO

02 May 2024, 02:18 AM
Zacks Investment Research

Core Laboratories (CLB) Q1 Earnings and Sales Beat Estimates

25 Apr 2024, 15:57 PM
Zacks Investment Research

Kinder Morgan (KMI) Beats on Q1 Earnings, Hikes Dividend

18 Apr 2024, 17:14 PM
Zacks Investment Research

Sunoco (SUN) Proceeds With Strategic Portfolio Optimization

18 Apr 2024, 17:13 PM
Zacks Investment Research

What Makes Core Laboratories (CLB) a New Strong Buy Stock

18 Apr 2024, 17:00 PM
GlobeNewswire Inc.

Christina Lake Cannabis Provides Bi-Weekly Update on Status of MCTO

18 Apr 2024, 00:28 AM
Zacks Investment Research

Earnings Preview: Core Laboratories (CLB) Q1 Earnings Expected to Decline

17 Apr 2024, 15:01 PM
GlobeNewswire Inc.

Christina Lake Cannabis Announces Delay in Filing its 2023 Annual Financial Statements

04 Apr 2024, 04:01 AM
Zacks Investment Research

Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio

03 Apr 2024, 14:50 PM
Zacks Investment Research

Why Core Laboratories (CLB) is a Top Value Stock for the Long-Term

29 Mar 2024, 13:40 PM
GlobeNewswire Inc.

Christina Lake Cannabis Provides Operations Update

12 Mar 2024, 00:39 AM
Zacks Investment Research

Core Laboratories (CLB) Down 0.4% Since Last Earnings Report: Can It Rebound?

01 Mar 2024, 16:30 PM
GlobeNewswire Inc.

Christina Lake Closes First Tranche of Non-Brokered Private Placement of Secured Convertible Notes

01 Mar 2024, 12:00 PM
GlobeNewswire Inc.

Christina Lake Announces Results of AGM

05 Feb 2024, 01:58 AM
Zacks Investment Research

Here's What Key Metrics Tell Us About Core Laboratories (CLB) Q4 Earnings

01 Feb 2024, 00:00 AM
Market Cap
615.85M
Enterprise Value
707.49M
P/E
21.4
P/B
2.29
P/S
1.17
EV / EBITDA
10.31
EV / Sales
1.35
EPS
0.62
Dividend Yield
0.3%
P/FCF
33.41
P/CF
17.94
Free Cash Flow
18.44M
ROE
10.7%
ROA
4.9%
Debt / Equity
0.43
Current Ratio
2.05
Quick Ratio
1.5
Cash
0.22
Avg Volume
540.12K
Fundamentals Snapshot Price
13.36

Income Statement

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Revenue 121.8M 138.26M 134.52M 130.16M 123.59M
Gross profit 19.72M 28.74M 29.62M 26.46M 24.12M
Operating income 1.89M 15.83M 20.93M 15.29M 4.42M
EBITDA 5.65M 19.5M 24.52M 18.96M 8.13M
Net income -789K 4.41M 14.52M 10.64M -154K
Basic EPS -0.02 0.1 0.31 0.23
Diluted EPS -0.02 0.1 0.31 0.22

Balance Sheet

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Total assets 587.73M 584.01M 591.36M 602.11M 591.52M
Total liabilities 312.58M 311.8M 313.97M 334.81M 332.16M
Total equity 275.14M 272.21M 277.39M 267.3M 259.36M
Cash & equivalents 22.82M 22.7M 25.63M 31.19M 22.11M
Current assets 214.37M 214.67M 226.91M 237.68M 228.77M
Current liabilities 104.73M 106.02M 95.74M 104.77M 103.73M

Cash Flow

Line Item 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1
Operating cash flow 3.97M 7.95M 8.5M 13.92M 6.66M
Investing cash flow -3.39M -3.75M 2.39M -1.64M 772K
Financing cash flow -457K -7.12M -16.45M -3.2M -4.48M
Change in cash 117K -2.93M -5.56M 9.08M 2.95M
Kind Filing Date Link
edgar index SCHEDULE 13G/A — Core Laboratories Inc. /DE/ View Filing
edgar index SD — Core Laboratories Inc. /DE/ View Filing
edgar index 8-K — Core Laboratories Inc. /DE/ View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 10-Q — Core Laboratories Inc. /DE/ View Filing
form 4 Form 4 — Tattoli Mark Damian View Filing
form 4 Form 4 — Tattoli Mark Damian View Filing
form 4 Form 4 — Tattoli Mark Damian View Filing
form 4 Form 4 — Tattoli Mark Damian View Filing
form 4 Form 4 — Tattoli Mark Damian View Filing
edgar index 8-K — Core Laboratories Inc. /DE/ View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
form 4 Form 4 — Carnes Martha Z. View Filing
form 4 Form 4 — Carnes Martha Z. View Filing
form 4 Form 4 — Carnes Martha Z. View Filing
form 4 Form 4 — MARTINOVICH ROBERT F View Filing
form 4 Form 4 — MARTINOVICH ROBERT F View Filing
form 4 Form 4 — MARTINOVICH ROBERT F View Filing
form 4 Form 4 — Temeng Kwaku View Filing
form 4 Form 4 — Temeng Kwaku View Filing
form 4 Form 4 — Temeng Kwaku View Filing
form 4 Form 4 — Klingensmith Harvey Robert View Filing
form 4 Form 4 — Klingensmith Harvey Robert View Filing
form 4 Form 4 — Klingensmith Harvey Robert View Filing
form 4 Form 4 — ANASTASIO CURT View Filing
form 4 Form 4 — ANASTASIO CURT View Filing
form 4 Form 4 — ANASTASIO CURT View Filing
form 4 Form 4 — Murray Katherine View Filing
form 4 Form 4 — Murray Katherine View Filing
form 4 Form 4 — Murray Katherine View Filing
edgar index SCHEDULE 13G/A — Core Laboratories Inc. /DE/ View Filing
edgar index 10-K — Core Laboratories Inc. /DE/ View Filing
edgar index 8-K — Core Laboratories Inc. /DE/ View Filing
eight k text 8-K — 8-K View Filing
ten k section 10-K — business View Filing
ten k section 10-K — mda View Filing
ten k section 10-K — risk_factors View Filing
edgar index 8-K/A — Core Laboratories Inc. /DE/ View Filing
edgar index 8-K — Core Laboratories Inc. /DE/ View Filing
eight k text 8-K — 8-K View Filing
edgar index NT 10-K — Core Laboratories Inc. /DE/ View Filing
edgar index SCHEDULE 13G/A — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index SCHEDULE 13G/A — Core Laboratories Inc. /DE/ View Filing
form 4 Form 4 — Teo Sow Hang View Filing
form 4 Form 4 — Bruno Lawrence View Filing
form 4 Form 4 — Hill Christopher Scott View Filing
form 4 Form 4 — Hill Christopher Scott View Filing
form 4 Form 4 — Gresham Gwendolyn View Filing
form 4 Form 4 — Tattoli Mark Damian View Filing
edgar index 8-K — Core Laboratories Inc. /DE/ View Filing
eight k text 8-K — 8-K View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
edgar index 4 — Core Laboratories Inc. /DE/ View Filing
form 4 Form 4 — Bruno Lawrence View Filing
form 4 Form 4 — Bruno Lawrence View Filing
form 4 Form 4 — Bruno Lawrence View Filing
form 4 Form 4 — Hill Christopher Scott View Filing
form 4 Form 4 — Hill Christopher Scott View Filing
form 4 Form 4 — Hill Christopher Scott View Filing
form 4 Form 4 — Gresham Gwendolyn View Filing
form 4 Form 4 — Gresham Gwendolyn View Filing